Pathogenic mechanism of congenital cataract caused by the CRYBA1/A3-G91del variant and related intervention strategies

Int J Biol Macromol. 2021 Oct 31:189:44-52. doi: 10.1016/j.ijbiomac.2021.08.111. Epub 2021 Aug 19.

Abstract

Congenital cataracts, which are genetically heterogeneous eye disorders, lead to visual impairment in childhood. In our previous study, we identified a novel mutation in exon 4 of the CRYBA1/BA3 gene, which resulted in the deletion of a highly conserved glycine at codon 91 (G91del) and perinuclear zonular cataract. The G91del variant is one of the most frequent pathogenic mutations in CRYBA1/BA3; however, its pathogenic mechanism remains unclear. In this study, we purified βA3-crystallin and the βA3-G91del variant. βA3-G91del was prone to proteolysis and exhibited very low solubility and low structural stability. Next, we constructed a CRYBA1/BA3 mutant cell model and observed that G91del mutant proteins were more sensitive to environmental stress and prone to form aggregates. Size-exclusion chromatography and molecular dynamics simulation showed that the G91del mutation impaired the ability of βA3 to form homo-oligomers. In addition, the protein folding process of βA3-G91del was complicated and showed more intermediate states, resulting in amyloid fiber aggregation and induction of cellular apoptosis. Finally, we investigated intervention strategies for congenital cataract caused by the CRYBA1/A3-G91del variant. The addition of lanosterol reversed the negative effects of the G91del mutation under external stress. This study may help explore potential treatment strategies for related cataracts.

Keywords: Amyloid fiber aggregation; CRYBA1/A3; Cataract-causing mutation; Cellular apoptosis; Intermediate states in protein folding; Lanosterol.

MeSH terms

  • Apoptosis / drug effects
  • Cataract / congenital*
  • Cataract / genetics*
  • Cell Line
  • Genetic Predisposition to Disease*
  • Guanidine / pharmacology
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Lanosterol / pharmacology
  • Mutant Proteins / chemistry
  • Mutant Proteins / metabolism
  • Mutation / genetics*
  • Protein Aggregates / drug effects
  • Protein Denaturation
  • Temperature
  • beta-Crystallin A Chain / chemistry
  • beta-Crystallin A Chain / genetics*
  • beta-Crystallin A Chain / ultrastructure

Substances

  • CRYBA1 protein, human
  • Mutant Proteins
  • Protein Aggregates
  • beta-Crystallin A Chain
  • Lanosterol
  • Guanidine